journal
https://read.qxmd.com/read/36913964/correction-to-lancet-neurol-2023-22-209-17
#1
(no author information available yet)
No abstract text is available yet for this article.
March 10, 2023: Lancet Neurology
https://read.qxmd.com/read/36907201/thrombolysis-for-acute-ischaemic-stroke-current-status-and-future-perspectives
#2
REVIEW
Georgios Tsivgoulis, Aristeidis H Katsanos, Else Charlotte Sandset, Guillaume Turc, Thanh N Nguyen, Andrew Bivard, Urs Fischer, Pooja Khatri
Alteplase is currently the only approved thrombolytic agent for treatment of acute ischaemic stroke, but interest is burgeoning in the development of new thrombolytic agents for systemic reperfusion with an improved safety profile, increased efficacy, and convenient delivery. Tenecteplase has emerged as a potential alternative thrombolytic agent that might be preferred over alteplase because of its ease of administration and reported efficacy in patients with large vessel occlusion. Ongoing research efforts are also looking at potential improvements in recanalisation with the use of adjunct therapies to intravenous thrombolysis...
March 9, 2023: Lancet Neurology
https://read.qxmd.com/read/36828008/encephalitis-matters
#3
JOURNAL ARTICLE
Ava Easton, Tom Pollak
No abstract text is available yet for this article.
February 21, 2023: Lancet Neurology
https://read.qxmd.com/read/36780915/endovascular-thrombectomy-for-basilar-artery-occlusion-translating-research-findings-into-clinical-practice
#4
REVIEW
Fana Alemseged, Thanh N Nguyen, Shelagh B Coutts, Charlotte Cordonnier, Wouter J Schonewille, Bruce C V Campbell
BACKGROUND: Basilar artery occlusion is a rare and severe condition. The effectiveness of endovascular thrombectomy in patients with basilar artery occlusion was unclear until recently, because these patients were excluded from most trials of endovascular thrombectomy for large-vessel occlusion ischaemic stroke. RECENT DEVELOPMENTS: The Basilar Artery International Cooperation Study (BASICS) and the Basilar Artery Occlusion Endovascular Intervention versus Standard Medical Treatment (BEST) trials, specifically designed to investigate the benefit of thrombectomy in patients with basilar artery occlusion, did not find significant evidence of a benefit of endovascular thrombectomy in terms of disability outcomes at 3 months after stroke...
February 10, 2023: Lancet Neurology
https://read.qxmd.com/read/36764322/epstein-barr-virus-as-a-cause-of-multiple-sclerosis-opportunities-for-prevention-and-therapy
#5
REVIEW
Francesca Aloisi, Gavin Giovannoni, Marco Salvetti
Multiple sclerosis is a chronic inflammatory disease of the CNS that results from the interplay between heritable and environmental factors. Mounting evidence from different fields of research supports the pivotal role of the Epstein-Barr virus (EBV) in the development of multiple sclerosis. However, translating this knowledge into clinically actionable information requires a better understanding of the mechanisms linking EBV to pathophysiology. Ongoing research is trying to clarify whether EBV causes neuroinflammation via autoimmunity or antiviral immunity, and if the interaction of EBV with genetic susceptibility to multiple sclerosis can explain why a ubiquitous virus promotes immune dysfunction in susceptible individuals...
February 7, 2023: Lancet Neurology
https://read.qxmd.com/read/36706773/diagnosis-of-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-international-mogad-panel-proposed-criteria
#6
REVIEW
Brenda Banwell, Jeffrey L Bennett, Romain Marignier, Ho Jin Kim, Fabienne Brilot, Eoin P Flanagan, Sudarshini Ramanathan, Patrick Waters, Silvia Tenembaum, Jennifer S Graves, Tanuja Chitnis, Alexander U Brandt, Cheryl Hemingway, Rinze Neuteboom, Lekha Pandit, Markus Reindl, Albert Saiz, Douglas Kazutoshi Sato, Kevin Rostasy, Friedemann Paul, Sean J Pittock, Kazuo Fujihara, Jacqueline Palace
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis and aquaporin-4-seropositive neuromyelitis optica spectrum disorder. Based on an extensive literature review and a structured consensus process, we propose diagnostic criteria for MOG antibody-associated disease (MOGAD) in which the presence of MOG-IgG is a core criterion. According to our proposed criteria, MOGAD is typically associated with acute disseminated encephalomyelitis, optic neuritis, or transverse myelitis, and is less commonly associated with cerebral cortical encephalitis, brainstem presentations, or cerebellar presentations...
January 24, 2023: Lancet Neurology
https://read.qxmd.com/read/36706772/mogad-comes-of-age-with-new-criteria
#7
JOURNAL ARTICLE
Francesc Graus, Josep Dalmau
No abstract text is available yet for this article.
January 24, 2023: Lancet Neurology
https://read.qxmd.com/read/36931809/correction-to-lancet-neurol-2023-22-191-92
#8
(no author information available yet)
No abstract text is available yet for this article.
April 2023: Lancet Neurology
https://read.qxmd.com/read/36931808/family-planning-considerations-in-people-with-multiple-sclerosis
#9
REVIEW
Kristen M Krysko, Ruth Dobson, Raed Alroughani, Maria Pia Amato, Riley Bove, Andrea I Ciplea, Yara Fragoso, Maria Houtchens, Vilija G Jokubaitis, Melinda Magyari, Azza Abdelnasser, Vasantha Padma, Sandra Thiel, Mar Tintore, Sandra Vukusic, Kerstin Hellwig
Multiple sclerosis is often diagnosed in patients who are planning on having children. Although multiple sclerosis does not negatively influence most pregnancy outcomes, less is known regarding the effects of fetal exposure to novel disease-modifying therapies (DMTs). The withdrawal of some DMTs during pregnancy can modify the natural history of multiple sclerosis, resulting in a substantial risk of pregnancy-related relapse and disability. Drug labels are typically restrictive and favour fetal safety over maternal safety...
April 2023: Lancet Neurology
https://read.qxmd.com/read/36931807/effect-of-atherosclerosis-on-5-year-risk-of-major-vascular-events-in-patients-with-transient-ischaemic-attack-or-minor-ischaemic-stroke-an-international-prospective-cohort-study
#10
JOURNAL ARTICLE
Philippa C Lavallée, Hugo Charles, Gregory W Albers, Louis R Caplan, Geoffrey A Donnan, José M Ferro, Michael G Hennerici, Julien Labreuche, Carlos Molina, Peter M Rothwell, Philippe Gabriel Steg, Pierre-Jean Touboul, Shinichiro Uchiyama, Éric Vicaut, Lawrence K S Wong, Pierre Amarenco
BACKGROUND: The prevalence of atherosclerosis and the long-term risk of major vascular events in people who have had a transient ischaemic attack or minor ischaemic stroke, regardless of the causal relationship between the index event and atherosclerosis, are not well known. In this analysis, we applied the ASCOD (atherosclerosis, small vessel disease, cardiac pathology, other causes, and dissection) grading system to estimate the 5-year risk of major vascular events according to whether there was a causal relationship between atherosclerosis and the index event (ASCOD grade A1 and A2), no causal relationship (A3), and with or without a causal relationship (A1, A2, and A3)...
April 2023: Lancet Neurology
https://read.qxmd.com/read/36931806/admission-systolic-blood-pressure-and-effect-of-endovascular-treatment-in-patients-with-ischaemic-stroke-an-individual-patient-data-meta-analysis
#11
JOURNAL ARTICLE
Noor Samuels, Rob A van de Graaf, Maxim J H L Mulder, Scott Brown, Bob Roozenbeek, Pieter Jan van Doormaal, Mayank Goyal, Bruce C V Campbell, Keith W Muir, Nelly Agrinier, Serge Bracard, Phil M White, Luis San Román, Tudor G Jovin, Michael D Hill, Peter J Mitchell, Andrew M Demchuk, Alain Bonafe, Thomas G Devlin, Adriaan C G M van Es, Hester F Lingsma, Diederik W J Dippel, Aad van der Lugt
BACKGROUND: Current guidelines for ischaemic stroke treatment recommend a strict, but arbitrary, upper threshold of 185/110 mm Hg for blood pressure before endovascular thrombectomy. Nevertheless, whether admission blood pressure influences the effect of endovascular thrombectomy on outcome remains unknown. Our aim was to study the influence of admission systolic blood pressure (SBP) on functional outcome and on the effect of endovascular thrombectomy. METHODS: We used individual patient data from seven randomised controlled trials (MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME, REVASCAT, PISTE, and THRACE) that randomly assigned patients with anterior circulation ischaemic stroke to endovascular thrombectomy (predominantly using stent retrievers) or standard medical therapy (control) between June 1, 2010, and April 30, 2015...
April 2023: Lancet Neurology
https://read.qxmd.com/read/36931805/safety-and-efficacy-of-pitolisant-in-children-aged-6-years-or-older-with-narcolepsy-with-or-without-cataplexy-a-double-blind-randomised-placebo-controlled-trial
#12
JOURNAL ARTICLE
Yves Dauvilliers, Michel Lecendreux, Gert Jan Lammers, Patricia Franco, Mikhail Poluektov, Christian Caussé, Isabelle Lecomte, Jeanne Marie Lecomte, Philippe Lehert, Jean Charles Schwartz, Giuseppe Plazzi
BACKGROUND: Narcolepsy is a life-long disorder characterised by excessive daytime sleepiness and cataplexy, often arising in childhood or adolescence. Pitolisant, a selective histamine H3 receptor inverse agonist, has been approved in Europe and USA for adults with narcolepsy with or without cataplexy, with a favourable safety profile. This phase 3 study aimed to assess the safety and efficacy of pitolisant in children with narcolepsy with or without cataplexy. METHODS: For this double-blind, randomised, placebo-controlled, multisite study, we recruited patients aged 6-17 years with narcolepsy with or without cataplexy in 11 sleep centres in five countries (Italy, France, Netherlands, Russia, and Finland)...
April 2023: Lancet Neurology
https://read.qxmd.com/read/36931804/lilyana-amezcua
#13
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2023: Lancet Neurology
https://read.qxmd.com/read/36931803/rigmor-h%C3%A3-jland-jensen-the-headache-warrior
#14
JOURNAL ARTICLE
Priya Venkatesan
No abstract text is available yet for this article.
April 2023: Lancet Neurology
https://read.qxmd.com/read/36931802/making-brain-health-a-global-priority
#15
JOURNAL ARTICLE
Udani Samarasekera
No abstract text is available yet for this article.
April 2023: Lancet Neurology
https://read.qxmd.com/read/36931801/the-international-stroke-recovery-and-rehabilitation-alliance
#16
LETTER
Julie Bernhardt, Dale Corbett, Sean Dukelow, Sean Savitz, John M Solomon, Rachel Stockley, Katharina S Sunnerhagen, Geert Verheyden, Marion Walker, Margit Alt Murphy, Anna Katharina Bonkhoff, Dominique Cadilhac, S Thomas Carmichael, Emily Dalton, Numa Dancause, Jodi Edwards, Coralie English, Erin Godecke, Kate Hayward, Sureshkumar Kamalakannan, Joosup Kim, Gert Kwakkel, Catherine E Lang, Natasha Lannin, Mindy Levin, Elizabeth Lynch, Gillian Mead, Juan Pablo Saa, Nick Ward
No abstract text is available yet for this article.
April 2023: Lancet Neurology
https://read.qxmd.com/read/36931800/the-polypill-from-a-public-health-perspective
#17
LETTER
Valery L Feigin, Michael Brainin, Sheila C O Martins
No abstract text is available yet for this article.
April 2023: Lancet Neurology
https://read.qxmd.com/read/36931799/action-needed-on-social-and-commercial-determinants-of-neurological-health-authors-reply
#18
LETTER
Sebastian Walsh, Richard Merrick, Carol Brayne
No abstract text is available yet for this article.
April 2023: Lancet Neurology
https://read.qxmd.com/read/36931798/action-needed-on-social-and-commercial-determinants-of-neurological-health
#19
LETTER
Dominick Collis, Keshav Harivardhan, Arani Nitkunan
No abstract text is available yet for this article.
April 2023: Lancet Neurology
https://read.qxmd.com/read/36931797/action-needed-on-social-and-commercial-determinants-of-neurological-health
#20
LETTER
Georgina Carr, Arani Nitkunan, Micha Vidot, James W Mitchell
No abstract text is available yet for this article.
April 2023: Lancet Neurology
journal
journal
20188
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.